Progression of polycystic kidney disease—a lack of progress?

被引：0
|
作者：
Stephen McDonald
Gopala Rangan
机构：
[1] Discipline of Medicine,
[2] University of Adelaide,undefined
[3] Royal Adelaide Hospital,undefined
[4] Westmead Millennium Institute for Medical Research,undefined
[5] University of Sydney,undefined
[6] Centre for Transplant and Renal Research,undefined
[7] Level 2,undefined
[8] Clinical Sciences Block,undefined
[9] Westmead Hospital,undefined
来源：
Nature Reviews Nephrology | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Despite an explosion in understanding of the disease process, the rates of patients with autosomal dominant polycystic kidney disease starting renal replacement therapy show no signs of slowing. Indeed, rates among people aged ≥70 years have increased, reflecting a greater propensity to offer renal replacement therapy to this age group.
引用
收藏
页码：489 / 491
页数：2
相关论文
共 50 条
  • [21] β-catenin ablation exacerbates polycystic kidney disease progression
    Conduit, Sarah E.
    Hakim, Sandra
    Feeney, Sandra J.
    Ooms, Lisa M.
    Dyson, Jennifer M.
    Abud, Helen E.
    Mitchell, Christina A.
    [J]. HUMAN MOLECULAR GENETICS, 2019, 28 (02) : 230 - 244
  • [22] Predictors of Autosomal Dominant Polycystic Kidney Disease Progression
    Schrier, Robert W.
    Brosnahan, Godela
    Cadnapaphornchai, Melissa A.
    Chonchol, Michel
    Friend, Keith
    Gitomer, Berenice
    Rossettit, Sandro
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (11): : 2399 - 2418
  • [23] The impact of chloride secretion on the progression of polycystic kidney disease
    Kraus, A.
    Faria, D.
    Schley, G.
    Schoedel, J.
    Grampp, S.
    Peters, D. J.
    Schreiber, R.
    Kunzelmann, K.
    Eckardt, K. -U.
    Buchholz, B.
    [J]. ACTA PHYSIOLOGICA, 2019, 227
  • [24] Slowing progression of autosomal dominant polycystic kidney disease
    Robert W. Schrier
    [J]. Nature Reviews Nephrology, 2015, 11 : 638 - 639
  • [25] Polycystic Kidney Disease Progression: Learning from Europe
    Cowley, Benjamin D., Jr.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (04) : 306 - 307
  • [26] Genetics and Autosomal Dominant Polycystic Kidney Disease Progression
    Corradi, Valentina
    Giuliani, Anna
    Gastaldon, Fiorella
    de Cal, Massimo
    Mancini, Barbara
    Montaldi, Anna
    Alghisi, Alberta
    Capelli, Irene
    La Manna, Gaetano
    Ronco, Claudio
    [J]. CURRENT PERSPECTIVES IN KIDNEY DISEASES, 2017, 190 : 117 - 123
  • [27] Impact of liver cysts in progression of polycystic kidney disease
    Idrizi, Alma
    Barbullushi, Myftar
    Beqiri, Arben
    Hoxha, Liri
    Koroshi, Alketa
    Spahia, Nereida
    Gjata, Margarita
    Xhaferri, Xhoana
    Bajrami, Valbona
    Thereska, Nestor
    [J]. CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2013, 8 (03): : 335 - 338
  • [28] Reversing the progression of polycystic kidney disease with an mTOR inhibitor
    Williams R.
    [J]. Nature Clinical Practice Nephrology, 2006, 2 (6): : 295 - 295
  • [29] Quinomycin A reduces cyst progression in polycystic kidney disease
    Radadiya, Priyanka S.
    Thornton, Mackenzie M.
    Daniel, Emily A.
    Idowu, Jessica Y.
    Wang, Wei
    Magenheimer, Brenda
    Subramaniam, Dharmalingam
    Tran, Pamela, V
    Calvet, James P.
    Wallace, Darren P.
    Sharma, Madhulika
    [J]. FASEB JOURNAL, 2021, 35 (05):
  • [30] Factors of progression in polycystic kidney disease and their therapy.
    Kraatz, G
    [J]. NIEREN-UND HOCHDRUCKKRANKHEITEN, 1997, 26 (06) : 252 - 256
12345